Ashva Capital Management

Business

Rigetti Computing Stock Upgraded to 'Buy' by B. Riley Following Major Quantum Computer Order from India

B. Riley analyst Craig Ellis has upgraded Rigetti Computing (NASDAQ: RGTI) from 'Neutral' to 'Buy', maintaining a $35 price target. The upgrade follows the company's announcement of an $8.4 million order to supply a 108-qubit quantum computer to India's premier R&D agency, C-DAC, providing clearer visibility into its 2026 commercial trajectory.

Jan 30, 2026

Business

Nvidia's AI Dominance: A Five-Year Outlook on Stock Performance and Market Trajectory

Fueled by explosive growth in AI infrastructure spending, Nvidia's commanding market position sets the stage for significant potential gains. Analysts project a revenue path that could see its stock reach new heights by the end of the decade.

Jan 30, 2026

Business

Analyst Defends Oracle as a 'Decade Stock' Despite Mounting Debt, AI Pressures

Oracle shares face continued pressure over debt and AI infrastructure costs, but Guggenheim's bullish $400 price target suggests potential for a multi-year rebound if execution risks are managed.

Jan 30, 2026

Business

Royal Caribbean Charts Aggressive Expansion with $5 Billion Fleet Investment, CFO Says

As demand surges post-pandemic, Royal Caribbean Group is committing billions to new ships and destinations. CFO Naftali Holtz details the balancing act between ambitious growth, shareholder returns, and leveraging AI to enhance the passenger experience.

Jan 30, 2026

Business

Box Unveils AI-Powered 'Extract' Platform, Fueling Analyst Optimism for Cloud Stock

Box, Inc. strengthens its enterprise cloud offerings with the general release of Box Extract, an AI-driven data intelligence tool. The launch coincides with bullish analyst sentiment, including a Citi price target suggesting significant upside.

Jan 30, 2026

Business

Verizon Bets on AI and Leaner Operations to Curb Customer Exodus

Facing stiff competition, Verizon is deploying AI at scale and restructuring its operations—funded partly by recent layoffs—to simplify customer interactions and rebuild loyalty in a saturated market.

Jan 30, 2026

World

Ukraine Scrambles to Fortify Air Defenses as Brief Russian Strike Pause Expires

As a temporary halt in Russian airstrikes on Kyiv brokered by former U.S. President Trump nears its end, Ukraine is urgently working to strengthen its air defenses. Analysts caution the lull may be a tactical move by Moscow to bolster its diplomatic leverage rather than a step toward peace.

Jan 30, 2026

Business

Bitcoin Tumbles to Two-Month Lows as Fed Uncertainty Sparks Fears of Prolonged Downturn

Bitcoin's sharp decline continues, breaching key support levels as experts warn of a potential slide toward $70,000. Market uncertainty fueled by Trump's controversial Fed chair nomination triggers a broader crypto sell-off.

Jan 30, 2026

Business

Brazilian Fintech Giant Nubank Clears Key U.S. Hurdle, Paving Way for National Bank and Potential Crypto Services

The U.S. Office of the Comptroller of the Currency has granted Nubank conditional approval to establish a national bank, a significant step that could see the digital banking leader offer federally regulated crypto custody alongside traditional banking products in the United States.

Jan 30, 2026

Business

Beyond the Minimum: How Your Credit Score Truly Shapes Your First Home Purchase

For aspiring homeowners, a credit score is more than just a gateway to a mortgage—it's a key determinant of long-term affordability. This guide breaks down the nuanced impact of credit on loan options, interest rates, and the strategic moves buyers can make to strengthen their financial position.

Jan 30, 2026

Business

Israel Bets on Nebius Group to Power National AI Ambitions with Supercomputer Contract

Nebius Group secures a pivotal government contract to operate Israel's national AI supercomputer, boosting its credibility and positioning it at the heart of the country's tech ecosystem, as analysts eye its growth potential.

Jan 30, 2026

Business

Biotech Showdown: Can Upstart Abivax Challenge Pharma Giant AbbVie in Immunology Race?

Investors face a classic choice between AbbVie's steady dividends and Abivax's high-risk, high-reward potential as both target lucrative immunology markets.

Jan 30, 2026

Business

A Tale of Two Havens: Silver's Supply Squeeze Diverges Sharply from Bitcoin's Macro Woes

Once hailed as twin hedges against fiat currency, silver and Bitcoin are now charting starkly different courses. Driven by a tangible industrial shortage, silver's historic rally contrasts with Bitcoin's slump, which is increasingly tethered to broader financial liquidity and risk sentiment.

Jan 30, 2026

Business

BeatBox Beverages Cuts 158 Jobs in Austin as Anheuser-Busch Acquisition Looms

Future Proof Brands, maker of the popular ready-to-drink brand BeatBox, is laying off over 150 employees at its headquarters. The move comes weeks after announcing a $490 million majority stake acquisition by Anheuser-Busch, signaling corporate restructuring ahead of the deal's expected close in early 2026.

Jan 30, 2026

Business

Markets on Edge: Bitcoin Tests $80K Support as Precious Metals Plunge

A sharp sell-off grips both digital and traditional safe havens, with Bitcoin nearing a critical $80,000 level and gold suffering its worst drop in months, fueled by Fed uncertainty and tech sector anxieties.

Jan 30, 2026

Business

Microsoft's AI Spending Jitters Spark Sell-Off, But Options Traders See a Bullish Opening

Microsoft shares tumbled 12% as investors questioned the return on its massive AI investments, despite strong cloud growth. The volatility has created a surge in bullish options activity, presenting strategic opportunities for long-term believers.

Jan 30, 2026

Business

Pfizer's $23 Billion Oncology Bet: CEO Albert Bourla's Post-Pandemic Quest to 'Save the World from Cancer'

After the COVID-19 windfall subsided, Pfizer CEO Albert Bourla is steering the pharmaceutical giant into a high-stakes, $23 billion pivot to cancer research. Facing a looming patent cliff and plummeting vaccine revenue, Bourla is betting on scientific innovation to secure the company's future—and redefine cancer treatment.

Jan 30, 2026

Business

Analyst Warns: XRP and Dogecoin Face Steep Declines in 2026 Amid Market Headwinds

As the cryptocurrency market grapples with sustained selling pressure, a new analysis highlights significant vulnerabilities for two of the most recognizable digital assets, XRP and Dogecoin, projecting potential losses exceeding 50% in the coming year.

Jan 30, 2026

Business

Gold at $5,000: Navigating the New Frontier for Retirement Portfolios in 2026

As gold breaches historic price levels, retirees face critical decisions on how to integrate the precious metal into their portfolios. We examine the trade-offs between physical bars, coins, and ETFs in a transformed market.

Jan 30, 2026

Business

U.S. Wholesale Prices Surge in December, Fueling Inflation Concerns

The Producer Price Index jumped 0.5% last month, more than double November's increase, as rising costs for machinery, metals, and travel services pointed to persistent pipeline pressures for consumers.

Jan 30, 2026